Paola Luciani has been appointed Full Professor of Pharmaceutical Technology at the University of Bern, Switzerland, in April 2019. She obtained her M.Sc. and Ph.D. in Chemical Sciences at the University of Rome La Sapienza, Italy, and subsequently worked as Postdoctoral Fellow at the Research Center for Colloids and Nanoscienceof the University of Florence, Italy. In 2009 she joined the Drug Formulation and Delivery Group of Professor Leroux at the ETH Zurich, Switzerland, as postdoctoral scientist and as group leader. In 2015 she was appointed Associate Professor for Phospholipids in Drug Development at the Institute of Pharmacy of the University of Jena, Germany (endowed professorship financially supported by Lipoid GmbH).
Prof. Luciani`s research is characterized by a multidisciplinary approach aimed at designing and developing lipid-based tools as delivery systems for protein, nucleic acids, drugs. Her research interests include also polymer- and peptide-based contrast agents for fluorescence functional imaging in inflammation and cancer.
Her research group is currently working on novel multimodal diagnostic and therapeutic approaches for fibrotic diseases, with a special focus on the molecular mechanisms and the intercellular communication underlying the oral administration of antifibrotic formulations. Additionally, the Luciani group started to explore the field of site-specific sustained release, working actively on the development of novel manufacturing processes for lipid-based depots as an alternative to current technologies for hydrophilic drugs and biomacromolecules.